PMID: 2489408Dec 1, 1989Paper

Cyclosporine in dermatology

Journal of the American Academy of Dermatology
A K GuptaJ J Voorhees

Abstract

Cyclosporine is a potent immunosuppressive agent with no appreciable effect on the bone marrow and a selective inhibitory effect on helper T cells. Oral cyclosporine was first used to prevent organ rejection but also has been reported to be effective in other disorders. In cutaneous diseases that respond to oral cyclosporine helper T cells appear to be involved in their pathogenesis. This article reviews the cutaneous diseases that have been treated with cyclosporine and its pharmacology and side effects. Two significant adverse side effects are renal dysfunction and hypertension, both of which are reversible when short-term low-dose (less than 5 mg/kg per day) oral cyclosporine is discontinued. Lymphoma is unlikely in an otherwise healthy patient who has received low-dose oral cyclosporine for limited periods. The use of oral cyclosporine in any patient should be carefully considered in terms of the risk/benefit ratio and needs to be carried out under close medical supervision. In view of the limited experience with cyclosporine in dermatology, whenever possible its use should be confined to formal clinical studies with established protocols and guidelines. Further controlled studies need to be performed to evaluate the effica...Continue Reading

Citations

Jan 1, 1991·Archives of Dermatological Research·J Péguet-NavarroJ Thivolet
May 1, 1991·International Journal of Dermatology·R P Rapini
Feb 1, 1995·The British Journal of Dermatology·M G DunnillD H McGibbon
Feb 12, 1998·The Australasian Journal of Dermatology·M J HuntR Armati
Apr 30, 2003·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·A StützJ G Meingassner
Aug 24, 2006·International Archives of Allergy and Immunology·Anton StuetzJosef G Meingassner
Jun 22, 2013·International Journal of Dermatology·Jung-Min ParkByung-Soo Kim
Jul 1, 1991·British Journal of Clinical Pharmacology·B D EdwardsA H Weston
Nov 1, 1990·Postgraduate Medical Journal·M H Rustin
Aug 2, 1990·The New England Journal of Medicine·D EisenJ J Voorhees
Jun 1, 1990·The British Journal of Dermatology·J S Ross, R D Camp
Apr 1, 1994·International Journal of Dermatology·A S Boyd, K H Neldner
Jan 1, 1995·Folia Microbiologica·Z Rehácek
Dec 10, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jamil R AzziSamir G Mallat
Jan 1, 1992·Clinical and Experimental Dermatology·G M KavanaghM M Black
Jan 16, 1992·The New England Journal of Medicine·T J Phillips, J S Dover
Sep 1, 1995·International Journal of Dermatology·D Y WilliamsG Varigos
Feb 1, 1993·The British Journal of Dermatology·N Sepp, P O Fritsch
Feb 12, 1998·The Australasian Journal of Dermatology·K E GeorgourasP J Brown
Nov 25, 2004·Experimental Dermatology·M GrassbergerT A Luger
Feb 1, 1994·Experimental Dermatology·L KeményT Ruzicka
Aug 1, 1990·The British Journal of Dermatology·Y MérotE Frenk
Nov 1, 1990·The British Journal of Dermatology·P PetzelbauerK Wolff
Sep 1, 1996·The British Journal of Dermatology·A F Finzi
May 1, 2001·International Journal of Dermatology·M MariniG Magariños
Sep 1, 1991·Clinical and Experimental Dermatology·C SoriaA Ledo
Nov 13, 2001·International Journal of Dermatology·R RaiB Kumar
Nov 9, 2005·American Journal of Veterinary Research·Claude FavrotMathias Ackermann
May 28, 2021·AAPS PharmSciTech·Prativa BiswasroyGoutam Rath
May 1, 1992·Journal of the American Academy of Dermatology·S E Wolverton

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.